109 related articles for article (PubMed ID: 8409949)
1. Topoisomerase I and II activities are required for Epstein-Barr virus replication.
Kawanishi M
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2263-8. PubMed ID: 8409949
[TBL] [Abstract][Full Text] [Related]
2. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Wong ML; Hsu MT
J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV.
Kawanishi M
Intervirology; 1995; 38(3-4):206-13. PubMed ID: 8682618
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].
Tsurumi T
Nihon Rinsho; 1997 Feb; 55(2):321-7. PubMed ID: 9046818
[TBL] [Abstract][Full Text] [Related]
5. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of topoisomerase II catalytic inhibitors against Epstein-Barr virus.
Wu T; Wang Y; Yuan Y
Antiviral Res; 2014 Jul; 107():95-101. PubMed ID: 24821256
[TBL] [Abstract][Full Text] [Related]
7. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
Beck WT; Danks MK
Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
[TBL] [Abstract][Full Text] [Related]
9. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.
Stevnsner T; Bohr VA
Carcinogenesis; 1993 Sep; 14(9):1841-50. PubMed ID: 8403208
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
Patel PC; Menezes J
Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
[TBL] [Abstract][Full Text] [Related]
11. Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases.
Fleischmann J; Kremmer E; Greenspan JS; Grässer FA; Niedobitek G
J Med Virol; 2002 Dec; 68(4):568-73. PubMed ID: 12376965
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cells.
Mattern MR; Tan KB; Zimmerman JP; Mong SM; Bartus JO; Hofmann GA; Drake FH; Johnson RK; Crooke ST; Mirabelli CK
Anticancer Drug Des; 1989 Aug; 4(2):107-24. PubMed ID: 2478139
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA topoisomerase I in the replication of herpes simplex virus type 2.
Yamada Y; Yamamoto N; Maeno K; Nishiyama Y
Arch Virol; 1990; 110(1-2):121-7. PubMed ID: 2155595
[TBL] [Abstract][Full Text] [Related]
14. C-1027-induced alterations in Epstein-Barr viral DNA replication in latently infected cultured human Raji cells: relationship to DNA damage.
McHugh MM; Beerman TA
Biochemistry; 1999 May; 38(21):6962-70. PubMed ID: 10346918
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition by ellipticine derivatives of the reactions catalysed by the topoisomerases: preferential inhibition of topoisomerase II].
Douc-Rasy S; Multon E; Kayser A; Riou G
C R Seances Acad Sci III; 1983; 296(19):899-904. PubMed ID: 6311366
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase.
Tsurumi T; Kobayashi A; Tamai K; Yamada H; Daikoku T; Yamashita Y; Nishiyama Y
Virology; 1996 Aug; 222(2):352-64. PubMed ID: 8806519
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
Snapka RM
NCI Monogr; 1987; (4):55-60. PubMed ID: 2819732
[TBL] [Abstract][Full Text] [Related]
18. A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis.
Narita Y; Sugimoto A; Kawashima D; Watanabe T; Kanda T; Kimura H; Tsurumi T; Murata T
Sci Rep; 2015 Jun; 5():11767. PubMed ID: 26123572
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
20. Architecture of replication compartments formed during Epstein-Barr virus lytic replication.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Shirata N; Tsurumi T
J Virol; 2005 Mar; 79(6):3409-18. PubMed ID: 15731235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
